Neueste Nachrichten

XORTX Announces USD $3 Million Offering 19.05.25 · globenewswire · XORTX Therapeutics Registered (Old)
XORTX Provides Update on FDA Type B Meeting Request 30.04.25 · globenewswire · XORTX Therapeutics Registered (Old)
XORTX Announces Grant of European Patent 28.04.25 · globenewswire · XORTX Therapeutics Registered (Old)
XORTX Announces Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency 18.04.25 · globenewswire · XORTX Therapeutics Registered (Old)
XORTX Announces Update for Discussion with the FDA 19.03.25 · globenewswire · XORTX Therapeutics Registered (Old)
XORTX Commences Gout Program NDA Discussions with the FDA 24.02.25 · globenewswire · XORTX Therapeutics Registered (Old)
XORTX to Present at Microcap Conference 29.01.25 · globenewswire · XORTX Therapeutics Registered (Old)
XORTX Announces Change of Auditor 17.01.25 · globenewswire · XORTX Therapeutics Registered (Old)
XORTX Adds Late Stage Gout Program to Pipeline 06.01.25 · globenewswire · XORTX Therapeutics Registered (Old)
XORTX Strengthens Executive Team 19.12.24 · globenewswire · XORTX Therapeutics Registered (Old)
XORTX Announces Presentation at the Rare and Genetic Disease Summit 12.12.24 · globenewswire · XORTX Therapeutics Registered (Old)
XORTX Sponsored Study Presented at the American Society of Nephrology – Kidney Week 2024 24.10.24 · globenewswire · XORTX Therapeutics Registered (Old)

Meistgelesen

XORTX Announces USD $3 Million Offering 104 Leser

XORTX Highlights Pioneering Research Indicating a Role for Genetic Regulation of Xanthine Oxidase ... 432 Leser
XORTX Announces Re-filing of YE 2023 and Q2 2024 MD&A 368 Leser
Independent Proxy Advisory Firm ISS Recommends XORTX Shareholders Vote FOR ALL Proposed Items at ... 348 Leser
XORTX Announces Filing and Mailing of the Meeting Documents in Connection with the Annual and ... 328 Leser
XORTX Announces Results of Annual and Special Meeting of Shareholders 320 Leser
XORTX Announces Presentation at American Society of Nephrology – Kidney Week 2024 288 Leser
XORTX Reminds Shareholders of Voting Deadline for Upcoming Annual and Special Meeting of ... 240 Leser
XORTX Initiates Precision Medicine Program 160 Leser
XORTX Strengthens Executive Team 160 Leser
XORTX Announces Update for Discussion with the FDA 140 Leser